Gene Therapy Applications for Fracture-Healing

Carofino, Bradley C.; Lieberman, Jay R.
February 2008
Journal of Bone & Joint Surgery, American Volume;Feb2008 Supplement 1, Vol. 90-A, p99
Academic Journal
Biologic therapies to promote fracture-healing such as use of bone morphogenetic proteins (BMPs) are being increasingly employed in multiple clinical scenarios. However, it has been challenging to design therapies that deliver sufficient quantities of protein over a sustained time period. A potential solution is the application of gene therapy that transfers genetic information to host cells at the fracture site, resulting in the continuous and localized production of the desired proteins. This approach has demonstrated tremendous potential in preclinical animal models of fracture-healing. This article will review the current state of gene therapy approaches to fracture-healing with an emphasis on potential clinical applications.


Related Articles

  • Use and efficacy of bone morphogenetic proteins in fracture healing. Lissenberg-Thunnissen, Suzanne; Gorter, David; Sier, Cornelis; Schipper, Inger // International Orthopaedics;Sep2011, Vol. 35 Issue 9, p1271 

    Purpose: This review evaluates the application of bone morphogenetic proteins (BMPs) in delayed bone repair, aiming at a broad audience from clinicians to scientists. Next to an overview of the role of the different BMPs, their antagonists and their current applications, special attention is...

  • Rat adipose-derived stromal cells expressing BMP4 induce ectopic bone formation in vitro and in vivo. Lin Lin; Xin Fu; Xin Zhang; Lian-xu Chen; Ji-ying Zhang; Chang-long Yu; Kang-tao Ma; Chun-yan Zhou // Acta Pharmacologica Sinica;Dec2006, Vol. 27 Issue 12, p1608 

    Aim: Bone morphogenetic protein 4 (BMP4) is one of the main local contributing factors in callus formation in the early phase of fracture healing. Adipose-derived stromal cells (ADSC) are multipotent cells. The present study was conducted to investigate the osteogenic potential of ADSC when...

  • Hot Ortho-Biologic Topics at AAOS 2011. Hoggatt, Julie // BioDrugs;2011, Vol. 25 Issue 3, p197 

    Several hot topics relating to ortho-biologics were discussed at the 2011 Annual Meeting of the American Academy of Orthopedic Surgery (AAOS) in San Diego this February. Injecting a patient's own platelet-rich plasma (PRP) prior to orthopedic surgery was an important topic, and had its own forum...

  • Building bone to reverse osteoporosis and repair fractures. Khosla, Sundeep; Westendorf, Jennifer J.; Oursler, Merry Jo // Journal of Clinical Investigation;Feb2008, Vol. 118 Issue 2, p421 

    An important, unfilled clinical need is the development of new approaches to improve fracture healing and to treat osteoporosis by increasing bone mass. Recombinant forms of bone morphogenetic protein 2 (BMP2) and BMP7 are FDA approved to promote spinal fusion and fracture healing, respectively,...

  • Biotherapeutics in Orthopaedic Medicine. Puleo, David A. // BioDrugs;2003, Vol. 17 Issue 5, p301 

    Musculoskeletal injuries have a significant human and financial impact on society. In particular, fractures that lead to delayed union or even nonunion represent a serious clinical challenge for which few treatment options are available. The multiple surgical procedures often needed are...

  • Expression and Activation of the BMP-Signaling Components in Human Fracture Nonunions. Kloen, Peter; Doty, Steven B.; Gordon, Eric; Rubel, IváN F.; Goumans, Marie-José; Helfet, David L. // Journal of Bone & Joint Surgery, American Volume;Nov2002, Vol. 84-A Issue 11, p1909 

    Background: The potential use of bone morphogenetic proteins (BMPs) to promote bone-healing is of great interest to orthopaedic surgeons. Although the complex mechanism leading from the local presence of BMP (whether endogenous or exogenous) to bone formation is increasingly understood, limited...

  • Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures. Govender, Shunmugam; Csimma, Cristina; Genant, Harry K.; Valentin-Opran, Alexandre // Journal of Bone & Joint Surgery, American Volume;Dec2002, Vol. 84-A Issue 12, p2123 

    Background:The treatment of open fractures of the tibial shaft is often complicated by delayed union and non-union. The objective of this study was to evaluate the safety and efficacy of the use of recombinant human bone morphogenetic protein-2 (rhBMP-2; dibotermin alfa) to accelerate healing of...

  • A Single Percutaneous Injection of Recombinant Human Bone Morphogenetic Protein-2 Accelerates Fracture Repair. Einhorn, Thomas A.; Majeska, Robert J.; Mohaideen, Ahamed; Kagel, Eric M.; Bouxsein, Mary L.; Turek, Thomas J.; Wozney, John M. // Journal of Bone & Joint Surgery, American Volume;Aug2003, Vol. 85-A Issue 8, p1425 

    Tests the hypothesis that a single, local, percutaneous injection of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) would accelerate fracture-healing in a standard rat femoral fracture model. Process used for the investigation on Sprague-Dawley rats; Observation from torsional...

  • bone morphogenetic protein.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p299 

    A definition of the term "bone morphogenetic protein" is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics